The centerpiece of the acquisition is Ohtuvayre, a treatment for chronic obstructive pulmonary disease that secured U.S. approval last year. The drug’s commercial launch has exceeded Wall Street ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Kaso sa Tuberculosis sa Davao Region, misaka og kapin 20% sa 2024 itandi niadtong 2023, sumala sa DOH-11 See what's fresh ...

To further strengthen the fight against tuberculosis, the Union Health Ministry will soon procure 1,500 more handheld X-ray machines to facilitate large-scale screening and early detection of cases, ...

Currently, around 500 such portable X-ray devices are deployed at screening centers across the country and over 46,000 Gram ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

NPs form the key to providing culturally competent care, which reduces health disparities and improves outcomes for Asian American patients.

Differentiated TB care involves tailoring services to individual needs of patients. Researchers pitch it as a model that can ...

Tulane University researchers have developed a new handheld TB test that significantly improves detection in people with HIV, ...